סך נכסים נקיים: Fulgent Genetics (FLGT)

Fulgent Genetics, Inc. (FLGT) specializes in laboratory diagnostics, leveraging the high cost of its oncogenetics services and the flexible creation of DNA panels. This chart of stock quotes confirms the market dynamics, where the indicator stands at 0.99. Experienced management is pivoting the company from PCR tests toward modern analysis methods. Simultaneously, the business is utilizing accumulated funds to acquire specialized laboratories, betting on inorganic growth.

The high scalability of the Fulgent Genetics, Inc. (FLGT) digital platform is directly reflected in the dynamics of the company's net asset value. This indicator captures the residual tangible capital after the full settlement of all liabilities. The metric measures the real value of resources available to shareholders, excluding the debt load. Growth in this figure confirms the efficiency of expanding genetic testing while maintaining stable costs. Investors should avoid impulsive buying during sharp spikes in the line without support from operating cash flow.